Studies have reported a higher frequency of mutations in DNMT3A, TET2, IDH1 and IDH2 in AML patients harboring trisomy 8 compared to those without this cytogenetic aberration [28,29]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.